tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Emily Bodnar, 250 are a BUY (85.03%), 44 are a HOLD (14.97%).
Analyst Emily Bodnar, carries an average stock price target met ratio of 32.18% that have a potential upside of 53.29% achieved within 96 days. Previously, Emily Bodnar worked at HC WAINWRIGHT.
Emily Bodnar’s has documented 514 price targets and ratings displayed on 30 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ACRV, Acrivon Therapeutics, Common Stock at 25-Nov-2025.
Analyst best performing recommendations are on BCTX (BRIACELL THERAPEUTICS CORP).
The best stock recommendation documented was for OLMA (OLEMA PHARMACEUTICALS) at 10/20/2025. The price target of $28 was fulfilled within 37 days with a profit of $20.23 (260.36%) receiving and performance score of 70.37.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$48
$0.45 (0.95%)
$48
2 years 4 months 3 days ago
(09-Aug-2023)
1/8 (12.5%)
$0.45 (0.95%)
85
Hold
$56
2 years 5 months 16 days ago
(26-Jun-2023)
0/1 (0%)
$27.35 (95.46%)
Hold
$48
$0.45 (0.95%)
$68
2 years 5 months 22 days ago
(20-Jun-2023)
1/3 (33.33%)
$1.56 (3.36%)
27
Hold
$48
$0.45 (0.95%)
$38
2 years 5 months 22 days ago
(20-Jun-2023)
1/2 (50%)
$1.56 (3.36%)
27
Hold
$48
$0.45 (0.95%)
$71
2 years 5 months 22 days ago
(20-Jun-2023)
0/2 (0%)
$1.56 (3.36%)
Which stock is Emily Bodnar is most bullish on?
Which stock is Emily Bodnar is most reserved on?
What Year was the first public recommendation made by Emily Bodnar?
